MARÍA DOLORES ARAGONÉS SANZ-rekin lankidetzan egindako argitalpenak (61)

1997

  1. Involvement of cyclic GMP in the mode of action of a new antithrombotic agent PCA-4230; inhibition of the platelet cyclic GMP dependent phosphodiesterase

    Thrombosis Research, Vol. 87, Núm. 6, pp. 547-557

  2. Regulation of PAF-induced platelet responses by cyclic nucleotides

    Platelets, Vol. 8, Núm. 2-3, pp. 147-154

1996

  1. Endothelin stimulates phosphoinositide hydrolysis and PAF synthesis in brain microvessels

    Journal of Cerebral Blood Flow and Metabolism, Vol. 16, Núm. 6, pp. 1325-1334

  2. Endothelin stimulates protein phosphorylation in blood-brain barrier

    Biochemical and Biophysical Research Communications, Vol. 219, Núm. 2, pp. 366-369

  3. Endothelin-stimulated phosphoinositide turnover and protein kinase C translocation in rat synaptosomes

    Biochemistry and Molecular Biology International, Vol. 38, Núm. 1 Included, pp. 7-14

  4. Identification of nitric oxide synthases in isolated bovine brain vessels

    Neuroscience Research, Vol. 25, Núm. 2, pp. 195-199

  5. Involvement of sphingolipids in the endothelin-1 signal transduction mechanism in rat brain

    Neuroscience Letters, Vol. 220, Núm. 2, pp. 121-124

  6. Protein phosphorylation in the blood-brain barrier. Possible presence of marcks in brain microvessels

    Neurochemistry International, Vol. 28, Núm. 1, pp. 59-65

  7. Regulation of phosphoinositide cycle by intracellular sodium in the blood-brain barrier

    Cellular Signalling, Vol. 8, Núm. 5, pp. 387-392

1995

  1. Endothelin-1 stimulates myristoylated alanine-rich C-kinase substrate (MARCKS) phosphorylation in rat cerebellar slices

    Neuroscience Letters, Vol. 194, Núm. 1-2, pp. 53-56

  2. Further studies on the mechanism of action of substance P in rat brain, involving selective phosphatidylinositol hydrolysis

    Neurochemical Research, Vol. 20, Núm. 10, pp. 1147-1153

  3. Involvement of calcium in phosphoinositide metabolism in the blood-brain barrier

    Cellular Signalling, Vol. 7, Núm. 3, pp. 261-267

  4. PCA-4248, a PAF receptor antagonist, inhibits PAF-induced phosphoinositide turnover

    European Journal of Pharmacology: Molecular Pharmacology, Vol. 290, Núm. 3, pp. 183-188

1994

  1. Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug

    Thrombosis Research, Vol. 75, Núm. 2, pp. 121-132

  2. Platelet-activating factor inhibits (Na+,K+) ATPase activity in rat brain

    Neuroscience Research, Vol. 19, Núm. 2, pp. 241-244

1993

  1. Identification of GTP Binding Proteins in Brain Microvessels and Their Role in Phosphoinositide Turnover

    Biochemical and Biophysical Research Communications, Vol. 195, Núm. 2, pp. 952-957

  2. PAF and thrombin actions in platelets are selectively affected by a new 1,4-dihydropyridine derivative

    Journal of Biochemistry, Vol. 113, Núm. 4, pp. 450-455

  3. Platelet-Activating Factor Stimulates Protein Kinase C Translocation in Cerebral Microvessels

    Biochemical and Biophysical Research Communications, Vol. 192, Núm. 2, pp. 446-451

  4. Tetrahydroaminoacridine affects the cholinergic function of blood-brain barrier

    Life Sciences, Vol. 53, Núm. 14, pp. 1165-1172

1992

  1. Inhibitory effect of insulin and cytoplasmic factor(s) on brain (Na+ + K+) ATPase

    Neuroscience Research, Vol. 13, Núm. 2, pp. 139-145